NL-OMON26299招募中不适用
A Diagnostic Accuracy Study to Evaluate the feasibility of the CardioWatch 287 in detecting heart rate and rr-intervals
MMT Swiss Connect0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational non invasive
入排标准
入选标准
- •Patients at CCN, scheduled for a resting ECG
- •Aged 18 years or above
排除标准
- •Under the age of 18
- •Subjects who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the subject's participation in this study.
研究者
相似试验
已完成
不适用
Feasibility Study to Assess Diagnostic Accuracy of Pathological Complete Response with Core Needle BiopsyInvasive Breast CancerJPRN-UMIN000012035Yokohama City University Medical Center80
招募中
1 期
se of axillary Ultrasound and FNAC in Breast CarcinomaCTRI/2018/02/011793Somendra Pal Singh team
招募中
不适用
Study of performance of Cxbladder tests to indicate whether patients are at low or high risk of bladder cancer when presenting with blood in urine.Bladder cancerhematuriaCancer - BladderRenal and Urogenital - Other renal and urogenital disordersACTRN12618000058279Pacific Edge Pty Ltd500
进行中（未招募）
1 期
A clinical study in men with prostate cancer undergoing surgery to assess the accuracy of 99mTc-MIP-1404 imaging as compared to pathology resultsProstate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864EUCTR2012-001864-30-BEMolecular Insight Pharmaceuticals, Inc100
进行中（未招募）
不适用
Phase 2 study to assess the effectiviness of the investigational drug 99mTc-MIP-1404 in detecting prostate cancer tissue within the prostate gland and elsewhere in human body.Prostate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 15.0Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-001864-30-HUMolecular Insight Pharmaceuticals, Inc100